Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Hum Hered 1998;48:82–86

Fluorescence in situ Hybridization of psu dic(X)(Xpter-Xq21::Xq21-Xpter) in Two Patients with Turner’s Syndrome

Fernández R.a · Pásaro P.a,b

Author affiliations

a Department of Psychobiology and b Institute of Health Science, University of A Coruña, Spain

Corresponding Author

Dr. Eduardo Pásaro Méndez

Department of Psychobiology, University of A Coruña

Campus Elviña, s/n

E–15071 A Coruña (Spain)

Fax 34 (9)81 16 71 53, E-Mail pspasaro@udc.es

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


Dicentric X chromosomes of different derivations were present in 6 out of a total of 42 patients with Turner’s syndrome. The most unusual cases were observed in 2 patients having a psu dic(X)(Xpter-Xq21::Xq21-Xpter) in mosaic form who were examined by fluorescence in situ hybridization. Alu-PCR products from hybrid cell lines were used as partial chromosome paints for the p arm of the human X chromosomes. The other 4 patients displayed isodicentric idic(Xq) in mosaic form. One of the patients displayed 9 cell lines originating from the accumulation of isodicentric idic(Xq) chromosomes, along with loss of chromosome material which resulted in fragments of varying size.

Article / Publication Details

First-Page Preview
Abstract of Original Paper

Published online: February 18, 1998

Number of Print Pages: 5
Number of Figures: 1
Number of Tables: 1

ISSN: 0001-5652 (Print)
eISSN: 1423-0062 (Online)

For additional information: http://www.karger.com/HHE

Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.